8 May 2023 in Salud, Ciencia y Tecnología - Serie de Conferencias
Propósito de la revisión: En Cuba se dispone actualmente de una alternativa en aquellos casos donde la realización del cariotipo no es posible o resulta no concluyente, en tales casos se descartan las principales aneuploidías empleando la hibridación fluorescente in situ. Su empleo resulta muy costoso e implica una carga intensa de trabajo. Entre los estudios moleculares que han ganado mayor repercusión en la literatura científica mundial como un medio para la determinación del número de copias de un segmento genómico está la amplificación múltiple de sondas dependiente de ligación. Objetivo: Evaluar a través del rastreo de la literatura científica a la amplificación múltiple de sondas dependiente de ligación como una técnica factible para su uso en la determinación de las principales aneuploidías. Método de búsqueda: Se realizaron búsquedas en Pubmed/Medline y Google académico. Se empleó la siguiente estrategia de búsqueda: “(MLPA OR multiplex OR ligation-dependent) AND (aneuploidy OR trisomy) AND amniotic”. Se seleccionaron solo artículos a texto completo; principalmente los que reflejan su empleo en el diagnóstico prenatal empleando líquido amniótico como muestra. Conclusiones: El empleo de la MLPA podría significar la obtención de resultados en menos tiempo, con menores costos por caso y menor carga laboral, entre otras ventajas. Sin embargo, los especialistas consideran que deben realizarse más estudios antes de emplearla como única técnica para la identificación de aneuploidías.
20 March 2024 in Egyptian Journal of Medical Human Genetics
Background: Von Hippel-Lindau (VHL) syndrome is an autosomal dominantly inherited disorder that predisposes to multiple neoplasms. Patients may develop hemangioblastomas of the central nervous system and retina, multiple cysts in the pancreas and kidneys, renal carcinoma, and pheochromocytomas, among other lesions. This disease is caused by germline genetic variants in the VHL gene. The regulation of the alpha subunit of hypoxia-inducible factor-1 is the key tumor suppressor function of the VHL protein. To date, more than seven hundred variants have been reported in VHL gene. This study aimed to investigate the molecular etiology of VHL syndrome in Cuban patients. Results: DNA samples from twenty-two individuals were analyzed by Sanger sequencing or enzymatic restriction. The analysis identified four novel pathogenic variants for the Cuban population: c.463 + 2T > C, C162W, R167W, and S183X, in addition to D121G and R161X, previously described in another work. The diagnosis was confirmed in seven patients with clinical manifestations and family history. Two at-risk family members without clinical signs were positive for presymptomatic diagnosis. Conclusions: The spectrum of germinal point mutations of VHL gene in Cuban patients was updated. The presence of genetic variants was ruled out in eight asymptomatic relatives, which is a psychological relief for these individuals. The results allow for offering other at-risk relatives the presymptomatic diagnosis and the possibility of receiving genetic counseling.
26 November 2025 in Salud, Ciencia y Tecnología - Serie de Conferencias
Cystic fibrosis is a common recessive disease in the Caucasian population. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can cause damage to the protein it encodes. Seven mutations are directly analyzed in Cuba, representing 55.5% of the pathogenic allelic variants in cystic fibrosis patients. The high allelic heterogeneity of this gene and its varied phenotypic expression make it vitally important to detect a greater number of genetic variants that cause the disease. With this data, patients can receive better genetic counseling and personalized treatment that would improve their quality of life. It is therefore necessary to search for new variants to complete the diagnosis. The objective of this work was to identify new genetic variants in the CFTR gene and confirm the clinical diagnosis of Cystic Fibrosis. Twenty-one patients clinically diagnosed as cystic fibrosis by the National Medical Genetics Network or identified as positive through the Neonatal Screening Program were analyzed. Eleven real-time polymerase chain reaction assays were performed on the isolated DNA, followed by high-resolution dissociation curve analysis. The amplification of these eleven fragments covered the five exons of the gene with the highest number of described mutations and the adjacent intronic regions. Subsequently, the samples that showed changes in the curve pattern were sequenced. Five mutations were detected: one pathogenic, two of uncertain significance, one benign, and one with conflicting clinical significance. Point genetic variants were identified in four of the five exons analyzed. The real-time polymerase chain reaction – high resolution melting curve technique proved useful for searching for point mutations along the CFTR gene sequence, which, in combination with Sanger sequencing, will allow for the identification of new variants in the Cuban population.
24 June 2024 in OBM Genetics
Silver-Rusell syndrome is a rare genetic disease. There is evidence that the genetic causes of the disorder are heterogeneous, with predominant alterations in the imprinted regions of chromosomes 11 and 7, in addition to other genomic alterations, such as chromosomal structural aberrations, single nucleotide polymorphisms, copy number variations, and small insertions and deletions. The most prevalent clinical manifestations include prenatal and postnatal growth retardation, dysmorphic features, and feeding difficulties. We present a case of a 4-year-old boy with phenotypic features consistent with Silver-Russell syndrome. The sample was subjected to conventional karyotyping analysis. The analysis was also conducted using the SALSA MLPA Probemix ME032-A1 UDP7-UDP14 and Applied Biosystems CytoScan 750K Suite. MS-MLPA analysis revealed the presence of hypermethylation in the GRB-10 and MEST genes on chromosome 7. SNP-array analysis revealed a loss of heterozygosity (LOH) at 7q11.22q31.1 (38.7 Mb). The methylation of the genes involved in this epigenetic event, in conjunction with LOH and the clinical characterization of this child, indicates that the origin of the disease is due to an isodisomy of maternal chromosome 7. This report of a child who exhibits the clinical characteristics of SRS and presents a UPD of chromosome 7, most likely originating from the mother, once again demonstrates the involvement of these genes in SRS despite the incomplete understanding of the underlying mechanism. A multidisciplinary strategy has been proposed for the follow-up and treatment of this disease according to its etiology in the proband.